Califorrniaa v. Vidal

Court of Appeals for the Federal Circuit·Decided November 7, 2022·No. 22-1640·Unpublished

Opinion

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit

EURICA CALIFORRNIAA,

Plaintiff-Appellant

v.

KATHERINE K. VIDAL, UNDER SECRETARY OF COMMERCE FOR INTELLECTUAL PROPERTY AND DIRECTOR OF THE UNITED STATES PATENT AND TRADEMARK OFFICE, Defendant-Appellee

2022-1640

Appeal from the United States District Court for the Eastern District of Virginia in No. 1:20-cv-00985-MSN- TCB, Judge Michael S. Nachmanoff.

Decided: Nov. 7, 2022

EURICA CALIFORRNIAA, Mahopac, NY, pro se.

DANA KAERSVANG, Appellate Staff, Civil Division, United States Department of Justice, Washington, DC, for defendant-appellee. Also represented by BRIAN M. BOYNTON, DANIEL TENNY; JESSICA D. ABER, MEGHAN LOFTUS, Office of the United States Attorney for the 2 CALIFORRNIAA v. VIDAL

Eastern District of Virginia, United States Department of Justice, Alexandria, VA; KAKOLI CAPRIHAN, BENJAMIN T. HICKMAN, THOMAS W. KRAUSE, BRIAN RACILLA, FARHEENA YASMEEN RASHEED, Office of the Solicitor, United States Patent and Trademark Office, Alexandria, VA.

Before LOURIE, DYK, and HUGHES, Circuit Judges.

PER CURIAM.

Eurica Califorrniaa appeals from the decision of the United States District Court for the Eastern District of Virginia granting summary judgment in favor of the United States Patent and Trademark Office (“PTO”). See Califorrniaa v. Hirshfeld, No. 1-20-cv-00985, 2021 WL 6196996 (E.D. Va. Dec. 20, 2021). We affirm.

BACKGROUND

Califorrniaa alleges that the PTO incorrectly calculated the Patent Term Adjustment (“PTA”) for his patent, U.S. Patent 10,245,075 (the “’075 patent”), by improperly deducting 51 days due to applicant delay.

Patent terms are generally extended by one day for each day of PTO delay, minus one day for each day during which the applicant fails to engage in reasonable efforts to conclude prosecution of the application. 35 U.S.C. § 154(b)(2)(C). 1 Congress delegated to the PTO the

1 35 U.S.C. § 154(b)(2)(C): Reduction of period of adjustment . —

(i) The period of adjustment of the term of a patent under paragraph (1) shall be reduced by a period equal to the period of time during which the applicant failed to engage in reasonable efforts to conclude prosecution of the application .

CALIFORRNIAA v. VIDAL 3

authority to define those situations that reflect a failure to engage in reasonable efforts to conclude prosecution of the patent. § 154(b)(2)(C)(iii). To avoid case-by-case determinations of what constitutes a failure to engage in reasonable efforts to conclude prosecution, it has promulgated regulations outlining examples of such efforts. See 65 Fed. Reg. 56366, 56378–79 (Sept. 18, 2000). It has defined an applicant’s amendment of a patent application after it issues a notice of allowance as one such failure. 37 C.F.R. § 1.704(c)(10). 2 Following our January 23, 2019

(ii) With respect to adjustments to patent term made under the authority of paragraph (1)(B), an applicant shall be deemed to have failed to engage in reasonable efforts to conclude processing or examination of an application for the cumulative total of any periods of time in excess of 3 months that are taken to respond to a notice from the Office making any rejection, objection, argument, or other request , measuring such 3-month period from the date the notice was given or mailed to the applicant.

(iii) The Director shall prescribe regulations establishing the circumstances that constitute a failure of an applicant to engage in reasonable efforts to conclude processing or examination of an application.

2 37 C.F.R. § 1.704(c)(10) (2019): Submission of an amendment under § 1.312 or other paper, other than a request for continued examination in compliance with § 1.114, after a notice of allowance has been given or mailed, in which case the period of adjustment set forth in § 1.703 shall be reduced by the lesser of:

(i) The number of days, if any, beginning on the date the amendment under § 1.312 or other paper was filed and ending on the mailing date of the Office action or notice in response to the amendment under § 1.312 or such other paper ; or (ii) Four months.

4 CALIFORRNIAA v. VIDAL

decision in Supernus, the PTO revised its regulations governing the calculation of PTA, including § 1.704(c)(10). Supernus Pharms., Inc. v. Iancu, 913 F.3d 1351 (Fed. Cir. 2019); 85 Fed. Reg. 36335, 36335 (June 16, 2020). This subsection was amended in June 2020 to (1) distinguish between after-allowance amendments expressly requested by the PTO, and those not, and (2) change the relevant timeframe for the calculation of a reduction in PTA. 37 C.F.R. § 1.704(c)(10) (2020) 3; 85 Fed. Reg. at 36335.

After an extensive prosecution involving numerous amendments, the examiner found that Califorrniaa’s patent could issue if minor additional changes were made to the claim language. C.A. 101–03. 4 The examiner made the amendment on his own authority and mailed the Notice of Allowance on December 11, 2018. C.A. 100. On January 7, 2019, Califorrniaa requested an additional interview, attaching a new proposed amendment to the interview request . C.A. 112–16. The interview was held the following day and included discussion of the potential amendment. Id. On January 10, 2019, Califorrniaa accordingly submitted a new amendment making minor changes (e.g., the addition of a comma) to some of the examiner-amended claim limitations, and several substantive changes (e.g., the

3 37 C.F.R. § 1.704(c)(10) (2020): Submission of an amendment under § 1.312 or other paper, other than an amendment under § 1.312 or other paper expressly requested by the Office or a request for continued examination in compliance with § 1.114, after a notice of allowance has been given or mailed, in which case the period of adjustment set forth in § 1.703 shall be reduced by the number of days, if any, beginning on the day after the date of mailing of the notice of allowance under 35 U.S.C. 151 and ending on the date the amendment under § 1.312 or other paper was filed.

4 “C.A.” refers to Appellee’s Corrected Appendix.

CALIFORRNIAA v. VIDAL 5

deletion of limitations) unrelated to the examiner amendment . C.A. 117–36. On February 26, 2019, the examiner responded and accepted the amendment. C.A. 140–161. The patent issued on April 2, 2019. C.A. 162.

The PTO, in calculating PTA, subtracted 51 days for the time that the plaintiff's after-allowance amendment was pending pursuant to 37 C.F.R. § 1.704(c)(10) (2019). At the time of calculation, § 1.704(c)(10) required a reduction of PTA for “[s]ubmission of an amendment under § 1.312 . . . after a notice of allowance has been given or mailed” by “the lesser of: (i) The number of days, if any, beginning on the date the amendment under § 1.312 or other paper was filed and ending on the mailing date of the Office action or notice in response to the amendment under § 1.312 or such other paper; or (ii) Four months.”

Pursuant to 35 U.S.C. § 154(3)(B)(ii), Califorrniaa timely filed a request for redetermination of PTA. C.A. 163–165. Califorrniaa argued that his only possible course of action to address the examiner’s amendment was to file his own after-allowance amendment, and therefore his actions did not constitute a failure to engage in reasonable efforts to conclude prosecution. The PTO found that the situation still fell within the rule, and that Califorrniaa would not benefit from an exception anyway because he sought changes unrelated to the examiner’s amendment and that it could have been made earlier. C.A. 6–7.

Free access — add to your briefcase to read the full text and ask questions with AI

Califorrniaa v. Vidal, (Fed. Cir. 2022).

Califorrniaa v. Vidal (Califorrniaa v. Vidal) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Norfolk Southern Railway Co. v. City of Alexandria
608 F.3d 150 (Fourth Circuit, 2010)
Gilead Sciences, Inc. v. Lee
778 F.3d 1341 (Federal Circuit, 2015)
Supernus Pharmaceuticals, Inc. v. Iancu
913 F.3d 1351 (Federal Circuit, 2019)
Intra-Cellular Therapies, Inc v. Iancu
938 F.3d 1371 (Federal Circuit, 2019)
Chudik v. Hirshfeld
987 F.3d 1033 (Federal Circuit, 2021)